Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2013
06/13/2013US20130150354 New selective ccr2 antagonists
06/13/2013US20130150350 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication
06/13/2013US20130150342 Pyrrolopyrimidine compounds as inhibitors of cdk4/6
06/13/2013US20130150341 Novel compounds
06/13/2013US20130150340 6-(4-Hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
06/13/2013US20130150310 Compositions and Methods for Treatment of Cancer
06/13/2013US20130146851 Compounds Having Semiconducting Properties and Related Compositions and Devices
06/13/2013CA2856551A1 Stereoselective total synthesis of noribogaine
06/13/2013CA2855994A1 Phosphate esters of noribogaine
06/13/2013CA2855990A1 Sulfate esters of noribogaine
06/13/2013CA2854603A1 Inhibitors of bruton's tyrosine kinase
06/12/2013EP2602255A1 Fused heterocyclic ring compound
06/12/2013EP2601194A2 Fused-imidazoyl compounds useful as antimicrobial agents
06/12/2013EP2601193A1 Compounds with antibacterial activity against clostridium
06/12/2013EP2600872A1 Fused-imidazoyl compounds useful as antimicrobial agents
06/12/2013EP2475657B1 5-alkinylthien-2-ylcarboxylic acids as inhibitors of flaviviridae viruses
06/12/2013EP2178869B1 Indole compounds as an inhibitor of cellular necrosis
06/12/2013CN1980710B Substituted azepine derivatives as serotonin receptor modulators
06/12/2013CN103155200A Organic electroluminescent element
06/12/2013CN103153999A Novel compound acting as a cannabinoid receptor-1 inhibitor
06/12/2013CN103153998A Materials for electronic devices
06/12/2013CN103153995A Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
06/12/2013CN103153994A Bicyclic heteroaryl kinase inhibitors and methods of use
06/12/2013CN103153984A Inhibitors of bruton's tyrosine kinase
06/12/2013CN103146223A Ultrasonic extraction method of exocarpium benincasae pigment
06/12/2013CN103145988A Polyimide oligomer and liquid photoimagable solder resist ink
06/12/2013CN103145718A Method for extracting sodium copper chlorophyllin from chlorella
06/12/2013CN103145717A Preparation method for phthalocyanine compound
06/12/2013CN103145716A Technique for preparing and separating cyclic dipeptide C6 from phellinus igniarius bacteria in high pressure opposite-phase mode
06/12/2013CN103145715A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
06/12/2013CN101903027B Preventive or therapeutic agent for inflammatory bowel disease
06/12/2013CN101674834B Inhibitors of bruton's tyrosine kinase
06/12/2013CN101600719B Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol
06/11/2013US8461352 Process for preparing azabicyclic compounds
06/11/2013US8461334 Process for resolving zopiclone
06/11/2013US8461330 Imidazotriazines and imidazopyrimidines as kinase inhibitors
06/11/2013US8461327 Diamine salts of carboxylic acids
06/11/2013US8461193 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
06/11/2013US8461172 Solid forms and process for preparing
06/11/2013US8461165 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
06/11/2013US8461162 Pyrazolo[1,5-a]pyrimidine derivatives
06/11/2013US8461152 Arylcyclohexylethers of dihydrotetraazabenzoazulenes
06/11/2013US8461151 Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
06/11/2013US8461150 Chalcone linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
06/11/2013US8461149 Compounds useful as protein kinase inhibitors
06/11/2013US8461142 Water-soluble anionic bacteriochlorophyll derivatives and their uses
06/11/2013CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
06/11/2013CA2546101C N-acylsulfonamide apoptosis promoters
06/06/2013WO2013082344A1 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
06/06/2013WO2013080141A1 Pyrazolopyrrolidine compounds
06/06/2013WO2013079745A1 Compounds that inhibit aggregation of the beta amyloid peptide
06/06/2013WO2013079589A1 Novel crystalline form of ticagrelor and process for the preparation thereof
06/06/2013WO2013079494A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
06/06/2013WO2013078544A1 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
06/06/2013WO2013052699A3 Novel quinoxaline inhibitors of pi3k
06/06/2013US20130143893 Piperazine derivatives and methods of use
06/06/2013US20130143889 Heterocycles As Potassium Channel Modulators
06/06/2013US20130143888 Phenoxymethyl heterocyclic compounds
06/06/2013US20130143870 Novel compounds
06/06/2013US20130143862 Certain amino-pyridazines, compositions thereof, and methods of their use
06/06/2013US20130143841 Benzoheterocyclic anti-bacterial agents
06/06/2013US20130142873 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
06/06/2013CA2857193A1 Heterocyclic amides compounds which are hdac6 inhibitors and used as anti-tumoral agents
06/06/2013CA2857155A1 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
06/06/2013CA2855242A1 Novel crystalline form of ticagrelor and process for the preparation thereof
06/06/2013CA2850593A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
06/05/2013EP2599781A1 Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
06/05/2013EP2599386A1 2-aminopyrimidine modulators of the histamine h4 receptor
06/05/2013EP2598507A1 Anticancer derivatives, preparation thereof and therapeutic use thereof
06/05/2013EP2598506A1 Process for the preparation of the compound osi - 906
06/05/2013EP2598505A2 Substituted imidazo[1,2-b]pyridazines
06/05/2013EP2598504A1 Process for the preparation of dimiracetam
06/05/2013EP2598144A1 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor
06/05/2013CN103140492A Semiconductors based on diketopyrrolopyrroles
06/05/2013CN103140491A Anticancer derivatives, preparation thereof and therapeutic use thereof
06/05/2013CN103130813A Electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, and gallium phthalocyanine crystal
06/05/2013CN103130812A Indolo[3,2,1-jk]carbazole derivative, preparation method and application
06/05/2013CN103130811A Synthesis method of 5,6-2H-pyrrolo[1,5-c] quinazoline compounds
06/05/2013CN103130810A Synthesis method of pyrrolo[1,5-c] quinazoline compounds
06/05/2013CN103130809A Separating method of cyclic dipeptide C1 from phellinus igniarius
06/05/2013CN103130808A Normal pressure reverse phase preparation and separating method of dipeptide C8 in phellinus igniarius
06/05/2013CN103130807A Separating method of cyclic dipeptide C9 from phellinus igniarius
06/05/2013CN103130806A Phenanthroindo(quio)lizidine alkaloid derivative, and preparation, anti-TMV activity, anti-HIV activity and anti-tumor activity thereof
06/05/2013CN103130792A 2-aminothiazoles compound
06/05/2013CN103130791A Novel benzamides compound
06/05/2013CN103130775A Indolinone derivatives serving as tyrosine kinase inhibitors
06/05/2013CN103127953A Thermosensitivity recyclable metalloporphyrin visible light degradation catalyst and preparation method thereof
06/05/2013CN102746309B 1-N-ethyl-4-N-2'-substituted acylhydrazine-1H-pyrazol [3, 4-d] miazines derivative as well as preparation method and application thereof
06/05/2013CN102219787B Method for synthesizing 4-hydroxy pyrazolo[3,4-d]pyrimidine
06/05/2013CN101619043B Quinazoline derivant and medical application thereof
06/05/2013CN101570505B Indole-2, 3-diformic ester compound and derivatives and synthetic method
06/05/2013CN101563351B Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
06/05/2013CN101433565B Total alkaloid extract of seeds of harmel genus, and preparation thereof
06/05/2013CN101133060B Enzyme inhibitors
06/04/2013US8455866 Heterocyclic compound and organic light-emitting device including the same
06/04/2013US8455661 Catalysts containing N-heterocyclic carbenes for enantioselective synthesis
06/04/2013US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group
06/04/2013US8455505 Pyrrolopyrimidinedione and its therapeutic use
06/04/2013US8455491 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]pyridazine and derivatives and pharmaceutical compositions comprising the same
06/04/2013US8455490 Facially amphiphilic polymers and oligomers and uses thereof
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 573